at
Knowledge4COVID-19
https://research.tib.eu/covid-19/entity/34854645
Property
Value
is
?:
annotates
of
<
https://research.tib.eu/covid-19/entity/34854645_HAS_TOPIC_C0003250
>
<
https://research.tib.eu/covid-19/entity/34854645_HAS_TOPIC_C0003253
>
<
https://research.tib.eu/covid-19/entity/34854645_HAS_TOPIC_C0086418
>
<
https://research.tib.eu/covid-19/entity/34854645_HAS_TOPIC_C0475463
>
<
https://research.tib.eu/covid-19/entity/34854645_HAS_TOPIC_C3542957
>
<
https://research.tib.eu/covid-19/entity/34854645_HAS_TOPIC_C4505220
>
<
https://research.tib.eu/covid-19/entity/34854645_HAS_TOPIC_C5203670
>
<
https://research.tib.eu/covid-19/entity/34854645_HAS_TOPIC_C5203676
>
<
https://research.tib.eu/covid-19/entity/34854645_HAS_TOPIC_C5392141
>
?:
authorAffiliation
[\'Amsterdam UMC, locatie AMC, afd. Infectieziekten, Amsterdam.\', \'Contact: Godelieve J. de Bree (g.j.debree@amsterdamumc.nl).\']
?:
citedBy
-1
?:
creator
<
https://research.tib.eu/covid-19/entity/Wiersinga_W_Joost
>
<
https://research.tib.eu/covid-19/entity/de_Bree_Godelieve_J
>
?:
doi
D6173
?:
doi
<
https://research.tib.eu/covid-19/entity/D6173
>
?:
hasPublicationType
<
https://research.tib.eu/covid-19/entity/Journal_Article
>
?:
journal
Nederlands tijdschrift voor geneeskunde
is
?:
pmid
of
<
https://research.tib.eu/covid-19/entity/34854645
>
?:
pmid
<
https://research.tib.eu/covid-19/entity/34854645
>
?:
pmid
34854645
?:
publication_isRelatedTo_Disease
<
https://research.tib.eu/covid-19/entity/Covid-19
>
?:
rankingScore_SJR
0.145
?:
rankingScore_hIndex
32
?:
title
[SARS-CoV-2 neutralizing monoclonal antibodies: a potential breakthrough in the early treatment of Covid-19 in high-risk patients].
?:
type
<
https://research.tib.eu/covid-19/vocab/Publication
>
<
https://research.tib.eu/covid-19/vocab/Publication_Author
>
?:
year
2021
Metadata
Anon_0
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataItem
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://www.w3.org/2004/03/trix/rdfg-1/Graph
>
<
http://xmlns.com/foaf/0.1/primaryTopic
>
<
https://research.tib.eu/covid-19/entity/34854645
>
<
http://xmlns.com/foaf/0.1/topic
>
Anon_0
<
http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes
>
<
https://research.tib.eu/covid-19/data/entity/34854645
>
<
http://purl.org/net/provenance/ns#createdBy
>
Anon_1
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataCreation
>
<
http://purl.org/net/provenance/ns#performedAt
>
2024-11-14T18:35:39.203Z
<
http://purl.org/net/provenance/ns#performedBy
>
Anon_2
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataProvidingService
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#Actor
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#DataCreatingService
>
<
http://purl.org/net/provenance/ns#deployedSoftware
>
Anon_3
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://usefulinc.com/ns/doap#Version
>
<
http://usefulinc.com/ns/doap#revision
>
0.4
<
http://www.w3.org/2000/01/rdf-schema#seeAlso
>
<
https://research.tib.eu/covid-19/
>
<
http://purl.org/net/provenance/ns#usedData
>
Anon_4
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataItem
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#QueryResult
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://www.w3.org/2004/03/trix/rdfg-1/Graph
>
<
http://purl.org/net/provenance/ns#retrievedBy
>
Anon_5
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataAccess
>
<
http://purl.org/net/provenance/ns#performedAt
>
2024-11-14T18:35:39.203Z
<
http://purl.org/net/provenance/ns#performedBy
>
Anon_2
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataProvidingService
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#Actor
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#DataCreatingService
>
<
http://purl.org/net/provenance/ns#deployedSoftware
>
Anon_3
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://usefulinc.com/ns/doap#Version
>
<
http://usefulinc.com/ns/doap#revision
>
0.4
<
http://www.w3.org/2000/01/rdf-schema#seeAlso
>
<
https://research.tib.eu/covid-19/
>
<
http://purl.org/net/provenance/ns#accessedService
>
<
https://labs.tib.eu/sdm/covid19kg/sparql
>
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#Actor
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#DataCreatingService
>
<
http://purl.org/net/provenance/ns#createdBy
>
Anon_6
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataCreation
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#QueryExecution
>
<
http://purl.org/net/provenance/ns#performedBy
>
<
https://labs.tib.eu/sdm/covid19kg/sparql
>
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#Actor
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#DataCreatingService
>
<
http://purl.org/net/provenance/ns#usedGuideline
>
Anon_7
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#SPARQLQuery
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://spinrdf.org/sp#Describe
>
<
http://www.w3.org/2000/01/rdf-schema#label
>
DESCRIBE <http://research.tib.eu/covid-19/entity/34854645>
expand all